Ignite Creation Date:
2025-12-24 @ 5:12 PM
Ignite Modification Date:
2026-01-02 @ 2:00 AM
Study NCT ID:
NCT07059650
Status:
RECRUITING
Last Update Posted:
2025-08-28
First Post:
2025-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)
Sponsor:
Dizal Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DZ2024B0001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None